On November 1, 2020, Sheridan Company adopted a stock-option plan that granted options to key executives to purchase 24,900 shares of the company's $9 par value common stock. The options were granted on January 2, 2021, and were exercisable 2 years after the date of grant if the grantee was still an employee of the company. The options expired 6 years from date of grant. The option price was set at $30, and the fair value option-pricing model determines the total compensation expense to be $373,500. All of the options were exercised during the year 2023: 16,600 on January 3 when the market price was $66, and 8,300 on May 1 when the market price was $77 a share. Prepare journal entries relating to the stock option plan for the years 2021, 2022, and 2023. Assume that the employee performs services equally in 2022 and 2023. (Credit account titles are automatically indented when amount is entered. Do not indent manually. If no entry is required, select "No Entry" for the account titles and enter for the amounts. Round intermediate calculations to 5 decimal places, e.g. 1.24687 and final answers to 0 decimal places, e.g. 5,125.) Date Account Titles and Explanation Debit Credit Jan. 2, 2021 ) No Entry No Entry 0 Dec. 31, 2021 9 Compensation Expense Paid-in Capital-Stock Options Dec 31, 2022 Compensation Expense Paid-in Capital-Stock Options (Jan. 3, 20239 Cash Paid-in Capital-Stock Options Common Stock Paid-in Capital in Excess of Par - Common Sto May 1, 20234) Cash Paid-in Capital-Expired Stock Options Common Stock Paid-in Capital in Excess of Par - Common Sto